Difficulty: Medium
Average Score: 89%
Practice
A 5-year-old patient had poor growth secondary to chronic kidney disease.
Correct answer
D
Rationale
In the scenario presented, the correct answer is D) recombinant GH (growth hormone). In a 5-year-old patient with poor growth due to chronic kidney disease, recombinant GH can be beneficial in stimulating growth and improving overall growth parameters. Chronic kidney disease can lead to growth failure due to various factors including hormonal imbalances, malnutrition, and metabolic disturbances. Recombinant GH can help address these issues by promoting growth and improving the patient's height velocity.
Option A) increased caloric intake may be important for overall nutritional support but may not directly address the growth failure related to chronic kidney disease.
Option B) correction of acidosis is important in managing chronic kidney disease, but it may not directly impact growth failure in this scenario.
Option C) correction of renal osteodystrophy is essential for bone health but may not directly address the growth failure in this case.
Educationally, understanding the implications of chronic kidney disease on growth in pediatric patients is vital for healthcare providers. Recognizing the role of recombinant GH in managing growth failure in these patients is crucial for providing comprehensive care. It highlights the multidisciplinary approach required in managing pediatric patients with chronic conditions, emphasizing the importance of endocrine management in such cases.
Option A) increased caloric intake may be important for overall nutritional support but may not directly address the growth failure related to chronic kidney disease.
Option B) correction of acidosis is important in managing chronic kidney disease, but it may not directly impact growth failure in this scenario.
Option C) correction of renal osteodystrophy is essential for bone health but may not directly address the growth failure in this case.
Educationally, understanding the implications of chronic kidney disease on growth in pediatric patients is vital for healthcare providers. Recognizing the role of recombinant GH in managing growth failure in these patients is crucial for providing comprehensive care. It highlights the multidisciplinary approach required in managing pediatric patients with chronic conditions, emphasizing the importance of endocrine management in such cases.